vs

Side-by-side financial comparison of Alignment Healthcare, Inc. (ALHC) and SCANSOURCE, INC. (SCSC). Click either name above to swap in a different company.

Alignment Healthcare, Inc. is the larger business by last-quarter revenue ($1.0B vs $766.5M, roughly 1.3× SCANSOURCE, INC.). SCANSOURCE, INC. runs the higher net margin — 2.2% vs -1.1%, a 3.2% gap on every dollar of revenue. On growth, Alignment Healthcare, Inc. posted the faster year-over-year revenue change (44.4% vs 2.5%). SCANSOURCE, INC. produced more free cash flow last quarter ($28.9M vs $-55.4M). Over the past eight quarters, Alignment Healthcare, Inc.'s revenue compounded faster (26.9% CAGR vs 0.9%).

Alignment Healthcare, Inc. is a U.S.-based healthcare provider offering Medicare Advantage plans for seniors. It adopts a value-based care model, partnering with local providers to deliver personalized coordinated medical services, prescription drug coverage and supplemental benefits to members across multiple U.S. states.

ScanSource, Inc. is a leading global specialty technology distributor offering a broad portfolio of solutions including point-of-sale systems, barcode scanning tools, cybersecurity products, cloud services and communication solutions. It primarily serves value-added resellers, managed service providers and enterprise clients across North America, Latin America and Europe, covering retail, healthcare, industrial and public sector core segments.

ALHC vs SCSC — Head-to-Head

Bigger by revenue
ALHC
ALHC
1.3× larger
ALHC
$1.0B
$766.5M
SCSC
Growing faster (revenue YoY)
ALHC
ALHC
+41.9% gap
ALHC
44.4%
2.5%
SCSC
Higher net margin
SCSC
SCSC
3.2% more per $
SCSC
2.2%
-1.1%
ALHC
More free cash flow
SCSC
SCSC
$84.3M more FCF
SCSC
$28.9M
$-55.4M
ALHC
Faster 2-yr revenue CAGR
ALHC
ALHC
Annualised
ALHC
26.9%
0.9%
SCSC

Income Statement — Q4 FY2025 vs Q2 FY2026

Metric
ALHC
ALHC
SCSC
SCSC
Revenue
$1.0B
$766.5M
Net Profit
$-11.0M
$16.5M
Gross Margin
13.4%
Operating Margin
-1.0%
2.3%
Net Margin
-1.1%
2.2%
Revenue YoY
44.4%
2.5%
Net Profit YoY
64.6%
-3.3%
EPS (diluted)
$-0.04
$0.75

Green = leading value per metric. Periods may differ when fiscal calendars don't align.

8-Quarter Revenue & Profit Trend

Side-by-side quarterly history. Quarters aligned by calendar period so offset fiscal years line up.

Revenue
ALHC
ALHC
SCSC
SCSC
Q4 25
$1.0B
$766.5M
Q3 25
$993.7M
$739.6M
Q2 25
$1.0B
$812.9M
Q1 25
$926.9M
$704.8M
Q4 24
$701.2M
$747.5M
Q3 24
$692.4M
$775.6M
Q2 24
$681.3M
$746.1M
Q1 24
$628.6M
$752.6M
Net Profit
ALHC
ALHC
SCSC
SCSC
Q4 25
$-11.0M
$16.5M
Q3 25
$3.7M
$19.9M
Q2 25
$15.7M
$20.1M
Q1 25
$-9.1M
$17.4M
Q4 24
$-31.1M
$17.1M
Q3 24
$-26.4M
$17.0M
Q2 24
$-24.0M
$16.1M
Q1 24
$-46.5M
$12.8M
Gross Margin
ALHC
ALHC
SCSC
SCSC
Q4 25
13.4%
Q3 25
14.5%
Q2 25
12.9%
Q1 25
14.2%
Q4 24
13.6%
Q3 24
13.1%
Q2 24
13.0%
Q1 24
12.6%
Operating Margin
ALHC
ALHC
SCSC
SCSC
Q4 25
-1.0%
2.3%
Q3 25
0.8%
3.5%
Q2 25
2.2%
3.3%
Q1 25
-0.6%
3.2%
Q4 24
-3.2%
2.5%
Q3 24
-2.8%
2.3%
Q2 24
-2.7%
2.9%
Q1 24
-6.5%
2.3%
Net Margin
ALHC
ALHC
SCSC
SCSC
Q4 25
-1.1%
2.2%
Q3 25
0.4%
2.7%
Q2 25
1.5%
2.5%
Q1 25
-1.0%
2.5%
Q4 24
-4.4%
2.3%
Q3 24
-3.8%
2.2%
Q2 24
-3.5%
2.2%
Q1 24
-7.4%
1.7%
EPS (diluted)
ALHC
ALHC
SCSC
SCSC
Q4 25
$-0.04
$0.75
Q3 25
$0.02
$0.89
Q2 25
$0.07
$0.87
Q1 25
$-0.05
$0.74
Q4 24
$-0.15
$0.70
Q3 24
$-0.14
$0.69
Q2 24
$-0.13
$0.66
Q1 24
$-0.25
$0.50

Balance Sheet & Financial Strength

Snapshot of each company's liquidity, leverage and book value from the latest quarter.

Metric
ALHC
ALHC
SCSC
SCSC
Cash + ST InvestmentsLiquidity on hand
$604.2M
$83.5M
Total DebtLower is stronger
$323.2M
Stockholders' EquityBook value
$179.3M
$910.9M
Total Assets
$1.1B
$1.7B
Debt / EquityLower = less leverage
1.80×

8-quarter trend — quarters aligned by calendar period.

Cash + ST Investments
ALHC
ALHC
SCSC
SCSC
Q4 25
$604.2M
$83.5M
Q3 25
$644.1M
$124.9M
Q2 25
$503.8M
$126.2M
Q1 25
$479.5M
$146.3M
Q4 24
$470.6M
$110.5M
Q3 24
$381.0M
$145.0M
Q2 24
$363.7M
$185.5M
Q1 24
$301.7M
$159.1M
Total Debt
ALHC
ALHC
SCSC
SCSC
Q4 25
$323.2M
Q3 25
$322.7M
Q2 25
$322.3M
Q1 25
$321.9M
Q4 24
$321.4M
Q3 24
$212.0M
Q2 24
$211.7M
Q1 24
$162.0M
Stockholders' Equity
ALHC
ALHC
SCSC
SCSC
Q4 25
$179.3M
$910.9M
Q3 25
$161.9M
$914.0M
Q2 25
$141.0M
$906.4M
Q1 25
$108.1M
$901.7M
Q4 24
$99.9M
$900.7M
Q3 24
$114.5M
$920.9M
Q2 24
$123.7M
$924.3M
Q1 24
$130.9M
$944.1M
Total Assets
ALHC
ALHC
SCSC
SCSC
Q4 25
$1.1B
$1.7B
Q3 25
$1.1B
$1.7B
Q2 25
$1.0B
$1.8B
Q1 25
$895.6M
$1.7B
Q4 24
$782.1M
$1.7B
Q3 24
$692.3M
$1.8B
Q2 24
$716.3M
$1.8B
Q1 24
$633.2M
$1.8B
Debt / Equity
ALHC
ALHC
SCSC
SCSC
Q4 25
1.80×
Q3 25
1.99×
Q2 25
2.29×
Q1 25
2.98×
Q4 24
3.22×
Q3 24
1.85×
Q2 24
1.71×
Q1 24
1.24×

Cash Flow & Capital Efficiency

How much cash each business actually produces after reinvestment. Cash flow is harder to manipulate than net income.

Metric
ALHC
ALHC
SCSC
SCSC
Operating Cash FlowLast quarter
$-50.4M
$30.8M
Free Cash FlowOCF − Capex
$-55.4M
$28.9M
FCF MarginFCF / Revenue
-5.5%
3.8%
Capex IntensityCapex / Revenue
0.5%
0.3%
Cash ConversionOCF / Net Profit
1.87×
TTM Free Cash FlowTrailing 4 quarters
$113.1M

8-quarter trend — quarters aligned by calendar period.

Operating Cash Flow
ALHC
ALHC
SCSC
SCSC
Q4 25
$-50.4M
$30.8M
Q3 25
$144.6M
$23.2M
Q2 25
$29.1M
Q1 25
$16.6M
$66.1M
Q4 24
$-8.7M
$-6.2M
Q3 24
$26.2M
$44.8M
Q2 24
$23.5M
Q1 24
$-6.2M
$160.2M
Free Cash Flow
ALHC
ALHC
SCSC
SCSC
Q4 25
$-55.4M
$28.9M
Q3 25
$139.1M
$20.8M
Q2 25
$21.1M
Q1 25
$8.4M
$64.6M
Q4 24
$-18.0M
$-8.2M
Q3 24
$16.9M
$42.5M
Q2 24
$11.8M
Q1 24
$-17.4M
$157.7M
FCF Margin
ALHC
ALHC
SCSC
SCSC
Q4 25
-5.5%
3.8%
Q3 25
14.0%
2.8%
Q2 25
2.1%
Q1 25
0.9%
9.2%
Q4 24
-2.6%
-1.1%
Q3 24
2.4%
5.5%
Q2 24
1.7%
Q1 24
-2.8%
21.0%
Capex Intensity
ALHC
ALHC
SCSC
SCSC
Q4 25
0.5%
0.3%
Q3 25
0.6%
0.3%
Q2 25
0.8%
0.3%
Q1 25
0.9%
0.2%
Q4 24
1.3%
0.3%
Q3 24
1.3%
0.3%
Q2 24
1.7%
0.2%
Q1 24
1.8%
0.3%
Cash Conversion
ALHC
ALHC
SCSC
SCSC
Q4 25
1.87×
Q3 25
38.77×
1.17×
Q2 25
1.86×
Q1 25
3.79×
Q4 24
-0.36×
Q3 24
2.64×
Q2 24
Q1 24
12.51×

Financial Flow Comparison

Revenue → gross profit → operating profit → net profit for each company.

Revenue Breakdown by Segment

ALHC
ALHC

Segment breakdown not available.

SCSC
SCSC

Products And Services$723.4M94%
Intelisys Advisory$25.0M3%
Recurring Revenue$18.2M2%

Related Comparisons